Lifeline Biotechnologies Pursues Prospective Major Breakthrough in Breast Cancer Detection Mar 20, 2007 11:59:00 AM Copyright Business Wire 2007
RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (OTCPK: LBTN) today announced that it is nearing a major breakthrough in the early detection of breast cancer. The new experimental classifying algorithms, the basis for Lifeline's First Warning System(TM), demonstrate sensitivity of 100% (the ability to find lesions in the breast) and two additional algorithms documented a specificity (the ability to distinguish benign from cancerous lesions) of 84% and 91% with its new neural network system which is nearing ready for clinical testing on large patient data sets.
Louis Keith, MD, PhD, Lifeline's Medical Director, stated, "For several decades medical researchers have struggled to find an accurate method for using the interpretation of thermal circadian data related to tumor growth in the breast as a detection modality. Many researchers believe the thermal data code of the breast's minute incremental temperatures changes are direct reflections of the breast's physiological activity and tumor growth."
Dr. Keith went on to say, "One in five women with breast cancer die of the disease; early detection is extremely important and should be the point of reference in evaluating any screening program. Past studies have shown that the characteristics of rhythmic changes in skin temperature of clinically healthy cancerous breasts are real and measurable. The superficial thermal patterns measured on the surface of the breast are related to tissue metabolism and vascularization within the underlying tissue. Cancer development appears to generate its own thermal signatures, and the complexity or lack thereof may be a reflection of its degree of development."
According to Lifeline's CEO, Jim Holmes, "These physiological phenomena led to the initial research in the mid-1980s by Lifeline's founder Dr. William Reeves and resulted in the development of prototype computer microprocessors capable of capturing these thermal aberrations as well as the development of the 'First Warning System(TM)' and ultimate patent protection of the technology and software."
About Lifeline Biotechnologies
SAFE HARBOR: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Source: Lifeline Biotechnologies, Inc.
----------------------------------------------
Lifeline Biotechnologies Inc. Investor Relations Rodney Marvel 866-THE-APPLE www.lbtn.com Posted by Happy Valley on :
volume pouring in.....
Posted by tompom on :
took my sell at .0003 awesome! riding some freebies here, you never know...
Posted by SherriT on :
Hope this will head north a bit - congrats tompom!
Posted by tompom on :
quote:Originally posted by SherriT: Hope this will head north a bit - congrats tompom!
thx Sherri hope you got some at .0001 lots of dilution going on here obviously...
Posted by Happy Valley on :
.0002's being gobbled up. Once the people who bought at .0001 are done flipping, maybe they will let it run, who knows....
Posted by netguy81 on :
nice pick ...
Posted by JacksonMS on :
MOMO coming in and all the news has been in the last 2 weeks. Looks like this one could turn into a runner. It showed up on the gainer list on subpennymarket.com
Posted by Happy Valley on :
If anyone is interested, this is the most recent share structure Pinksheets has listed, from 4/5/06.....Judging by todays volume I would not make any decisions based upon it.....
Volume is over 2 billion.....Makes me wonder if the shares I decided to hold onto will make me the next lottery winner or bagholder.....hmmmmmm
Posted by megahead34 on :
I put in an order...lets see if it will go through.
Posted by Happy Valley on :
Posted by: KingVegita2006 In reply to: None Date:3/20/2007 3:57:56 PM Post #of 2518
share structure update
As per your request, there are 60,183,570 Restricted Shares and 7,707,162,501 Shares of Lifeline Biotechnologies Inc as of March 19, 2007. If you have any questions feel free to contact me.
Regards, Toni Zaks Administrative Director
OTC CORPORATE TRANSFER SERVICE CO. 52 MAPLE RUN DRIVE, JERICHO, NY 11753 516-932-2080 OFFICE 516-932-2078 FAX
Posted by megahead34 on :
Ok, it didn't go through. I'll be so disappointed if it gaps up in the morning.
Posted by jgygli on :
Genetic Engineering and Biotech magazine listed the PR today as Breaking News
Posted by netguy81 on :
i finally decided to get in ... lets see if this soars tomorrow or in the next week or just stays there and makes me a bagholder (given the huge O/S) ...
anyway good luck to everyone here !!
Posted by beechwood on :
How many of you filled at .0001?
Posted by jgygli on :
I found this in NewsRX:
Medical News Article on Endoscopy
Lifeline Biotechnologies Reacquires First Warning System
2007 MAR 20 -- Lifeline Biotechnologies, Inc. (OTCPK: LBTN) announced that the Company has reached an agreement with Solos Endoscopy, Inc., wherein Lifeline has reacquired ownership including all rights to continue the development and marketing of the First Warning System(TM). The First Warning System(TM) is designed to assist in early detection of breast cancer. "An agreement has been reached with Solos Endoscopy whereby Lifeline will pursue the development and testing of the First Warning System(TM) as a very high priority.
Posted by Hitman on :
Had a sell order in for months.... sold 1000000 today at .0002 FYI My Laptop was having problems was gettin it fixed.... Just saw the sell... wow lots of volume
Posted by Igor R on :
Outstanding Shares: 6,650,250,000 as of 2007-01-22
Estimated Market Cap: 1.33M as of 2007-03-20 (based on Outstanding Shares as of 2007-01-22) Authorized Shares: 9,500,000,000 as of 2007-01-22 Number of Shareholders of Record: 9,500 as of 2007-01-22
From pinksheets.com, if this is the case, how in the world can this stock move with 6 billion outstanding, thats insane.
Posted by jgygli on :
In my readings, I am finding there is a close relationship with Solos (SLSY *.80pps). This is not a scam folks! I believe they reaised money to re-aquire this product by R/S and Dilution which I feel is over with!
I found this under a SLSY thread on another board:
By: pennystocker
What are your opinions on this announcement? I feel this could be very good news or very bad news. The reason I think that this could be very good news is because if lifeline does bring this first warning system to the market sometime soon, hopefully, it would be huge for the stock and could revolutionize the breast cancer screening industry. If this first warning system was FDA approved that would drive lifelines stock prices through the roof. And considering the fact that one of the top doctors in the world in womens medical conditions and treatments is on the board of Lifeline (Dr. Louis Keith vice president of Lifeline Biotechnologies) it seems like a good possibility that he feels this First Warning system is a revolutionary product in the breast cancer screening industry.
Posted by megahead34 on :
I'm in!
Posted by Happy Valley on :
Did u try to get in at .0001 or are they only letting shares go at the ask.....
Posted by megahead34 on :
at the ask
Posted by Happy Valley on :
Accumulation today....Still a few blocks being dumped at .0001, but it looks as if the majority of todays 180 million is at the ask......
Posted by MichaelAdamGreen on :
Beechwood - I filled 5,000,000 at .0001
Posted by Happy Valley on :
quote:Originally posted by Happy Valley: Volume is over 2 billion.....Makes me wonder if the shares I decided to hold onto will make me the next lottery winner or bagholder.....hmmmmmm
Bagholder it is.....Lucky me
Posted by Gary59 on :
I filled 50 buck worth at .0001 and now no MMs is even at bid now
Posted by megahead34 on :
quote:Originally posted by Happy Valley:
quote:Originally posted by Happy Valley: Volume is over 2 billion.....Makes me wonder if the shares I decided to hold onto will make me the next lottery winner or bagholder.....hmmmmmm
Bagholder it is.....Lucky me
What do you mean?
Posted by Happy Valley on :
Check out the bid......
Posted by Gary59 on :
Well UBSS is back on bid now
Posted by megahead34 on :
What is it on? Scottrade isn't working for me.
Posted by Gary59 on :
Scottrade was showing bid at -1.00 until UBSS came back on to bid ,, L2s showing they are only MM on bid now
Posted by Gary59 on :
MMs working this one now sending trade signals for .0002 for 500 sh thats 10 cents worth of shares Posted by Happy Valley on :
LOL....Not sure if it was the MM's or someone willing to sacrifice the commission to make their portfolio green eod, either way I guess we closed even today........
Posted by Happy Valley on :
Megahead...These are free so they are not real time level II quotes, so you will have to hit the refresh button from time to time in order for them to update, they will however give you an idea throughout the day how the level II's are looking. Hope this helps....GLTY
Still a rumor of a Pr for Thursday, will have to see!
Posted by TopRob on :
Everybody is buying and the pps is still at .0001 so it must be dilution in progress. OS is probably up to 10B by now. Could be a pump n dump scam. If it makes it to .0004 then it might be real, so I'll jump in then. If it never make it that high then scam city just like JMCP oil deal.
Posted by Gary59 on :
jgygli ,,, where are you hearing about a rumor of Pr today ?? Man volume way down this morning, would be nice to see Pr this morning
Posted by Chris4205 on :
This was on IHUB:
Lifeline Biotechnologies Prepares to File New Patent on Breast Cancer Detection [GVTVMFX]
RENO, Nev.--(Business Wire)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced that it is nearing a patent filing on its major breakthrough technology in the early detection of breast cancer.
Jim Holmes, CEO of Lifeline Biotechnologies, stated that "This technology advance has the potential of revolutionizing the way, timing and results this breakthrough holds in the assistance of detection of breast cancer. It means that, potentially, breast cancer could be identified in a greater number of patients, that is the accuracy could reduce the number of false positives and also reduce the number of needless biopsies. There are approximately 35 million mammograms a year in the United States. From which there are approximately one million biopsies. From this number of biopsies, approximately 200,000 to 250,000 cancers are identified. In other words, there are some 750,000 to 800,000 biopsies from which there are no cancers. We think our system has the potential of substantially reducing this number."
About Lifeline Biotechnologies, Inc.:
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's technologies, designed to assist in the early detection of cancers, deal with cutting edge innovation to assist practicing physicians in the delivery of quality medical care.
SAFE HARBOR: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Lifeline Biotechnologies, Inc. Investor Relations Rodney Marvel, 1-866-THE-APPLE www.lbtn.com
Copyright Business Wire 2007 22Mar07 14:25 GMT Symbols: us;LBTN Source BW Business Wire Categories: MST/I/BTC MST/I/MDV MST/L/EN MST/R/NME MST/R/US MST/R/US/NV TGT/BWB
Posted by Gary59 on :
Well volume really took off on that pr but no price changes....
Posted by Happy Valley on :
This is exactly what this stock needs, steady accumulation at the ask....Looks like NITE and AUTO have joined UBSS on the bid as well...
Posted by megahead34 on :
Nice PR!
Posted by Gary59 on :
Close to the same volume as yesterday at this time, hope it runs up a little with all the volume today..
Posted by wareagle206 on :
Quick poll? Where could this thing jump to?
Posted by Happy Valley on :
Bid support building, now up to 4 MM's *.0001.........
Posted by Happy Valley on :
Make that 5 now......
Posted by netguy81 on :
do any of you think this will go to 0.0003 today !!
Posted by Gary59 on :
Not without firm news on patent for product .. last 18 mill shrs traded where sells at .0001 \ JMHO
Posted by Happy Valley on :
I agree, without firm patent news, this stock needs a little time to accumulate and recover from the last two afternoons....Bid support continues to build (up to 6x.0001) so that is encouraging....imo
Posted by netguy81 on :
coool .... so lets wait and watch for more on the patent !!
any idea how long would it take to file the patent and get approved etc ...
Posted by Happy Valley on :
Lifeline Biotechnologies' Classification of Breast Cancer is No Longer a Myth but a Fact Tuesday March 27, 12:12 pm ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK: LBTN) today announced that its Neural Network Classification of breast cancer with blind temperature screening is no longer a myth but a fact. ADVERTISEMENT
According to Louis Keith, MD, PhD, Lifeline Biotechnologies, Medical Director and Vice President, "Predicting the future with Artificial Intelligence has always been a hit or miss proposition. Predictions have been made on computers whose functional capacities were limited but ever increasing. This means, in practical terms, that yesterday's predictions, however good, became out of date with the next generation of computers."
Jim Holmes, Lifeline's CEO, stated, "After almost three years of investigation, an entirely new neural network has been developed, which has become the basis of a new Lifeline patent application on thermal interpretation. Our system had been under trained. We had the correct ideas with Artificial Intelligence, but we had no idea that we had not pushed our system to its ultimate limits. Lifeline Biotechnologies is now on the right path. These new results are soon to appear in a major peer review medical journal."
About Lifeline Biotechnologies, Inc.:
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's technologies, designed to assist in the early detection of cancers, deal with cutting-edge innovation to assist practicing physicians in the delivery of quality medical care.
SAFE HARBOR: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact: Lifeline Biotechnologies, Inc. Investor Relations Rodney Marvel, 866-THE-APPLE www.lbtn.com
-------------------------------------------------------------------------------- Source: Lifeline Biotechnologies, Inc.
Posted by netguy81 on :
nice pr ... this should generate a lot of volume tomorrow and hopefully it will go up to 0.0003 !!
Posted by Happy Valley on :
I especially liked the part about being published in a major medical journal......
Posted by Happy Valley on :
Huge volume at the bid again today...Called TA's office this afternoon to confirm share structure, said he would call me back "within the hour" with the current numbers...Still have not heard back from him...His incompetence to return a simple phone call to a shareholder of a company he is supposed to be representing is all the info I need...Remember whether you have 10 shares or 20 million as a shareholder you are entitled to this information, and you certainly should not have to jump through hoops to get it...I have heard other people say the TA they spoke with regarding LBTN was very helpful, so maybe I got the disgruntled guy in the office...Either way I'm out at .0001...This is the TA's phone number if anybody else wants to try and get some answers... 516-932-2080....GLTYA
Posted by Happy Valley on :
Just heard back from the TA, I jumped the gun by saying he was the disgruntled employee in the office lol, he was actually quite helpful...He explained that he is the only person in the office for the next couple of days and appologized for the tardiness of his phone call...These are the updated numbers as of today.
Draw your own conclusions......GLTYA
Posted by lukin4winners on :
This could be the next super sub multi bagger multi day runner ....why not? IT has all the poetential in the world and with an extremely important possible medical remedy for breast cancer: Lifeline BioTechnologies CEO Featured in Exclusive Interview with WallSt.net Mar 29, 2007 7:00:00 AM NEW YORK, March 29 /PRNewswire/ -- On March 27, Jim Holmes, Chief Executive Officer for Lifeline BioTechnologies, Inc. (Pink Sheets: LBTN) updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, upcoming strategic and financial milestones.
To hear the interview in its entirety, visit www.wallst.net , and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window.
Posted by Hitman on :
I put in to buy 911911 shares today all or none at .0001 will c what happens
Posted by MichaelAdamGreen on :
It will fill - I filled 5 million yesterday, and can't sell any of it at .0002!!!
Posted by Hitman on :
May be a good buy... Just never know. If I buy i will hold as a Lotto Ticket for a while
Posted by netguy81 on :
in green today ... not bad ... hopefully it will up in the next week
Posted by HerbL_Remdy on :
Michael i too filled 2.5 mil at .0001 last Thursday....gtc sale for .0002 set Fri am....nada zip!
Posted by wes19c on :
Up 100% today!!
Posted by lukin4winners on :
NEWS out today looks very interesting. Business Wire "US Press Releases "
RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced the Company is offering a share exchange program to its common stock shareholders. Lifeline Biotechnologies, Inc. will offer to exchange its Series B Convertible Preferred Stock, to be valued by the Company at $1.00 per share, for common shares of stock held by its shareholders as of the record date, which the Company is valuing at $.001 per share, a premium to the current market price. This means for every 1,000 shares of common stock submitted to the Company for exchange, shareholders will receive one share of Series B Convertible Preferred Stock valued at $1.00 for future conversion purposes.
Current shareholders must have their shares into OTC Corporate Transfer Service Company by May 4, 2007, unless extended by the Company, in order to qualify for the exchange of common shares to Series B Convertible Preferred Shares. In order to qualify for the exchange, shareholders must submit a minimum of 100,000 shares of common stock. The Series B Convertible Preferred Stock will be protected from any future stock restructuring by the Company. For the complete terms and conditions of the stock exchange program, the Company will be posting particulars on its website www.lbtn.com. In addition, the Company will prepare and mail to its shareholders of record an Information Statement disclosing the terms and conditions of the exchange.
"We are very pleased to be able to offer our shareholders this exchange program. With the program announcement today, we are reaffirming our confidence and optimism in the long-term future of the Company. As more information becomes available, it will be provided on our website and/or through press releases," stated Jim Holmes, President of Lifeline Biotechnologies, Inc.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of disease conditions. The Company's technologies, designed to assist in the early detection of cancers, deal with cutting-edge innovation to assist practicing physicians in the delivery of quality medical care. The First Warning System(TM), a process for assisting in the early detection of breast cancer, is continuing to be developed by the Company. More information is available at the company's website: www.lbti.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Exchange Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including, without limitation, the ability to obtain financing and regulatory and shareholder approval for anticipated actions.
To automatically receive instant updates, press releases and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.
Source: Lifeline Biotechnologies, Inc
Posted by Hitman on :
Could hit .0004 today
Posted by megahead34 on :
I don't understand this PR.
Posted by madmoney on :
quote:Originally posted by megahead34: I don't understand this PR.
they are looking for common stock share holders to exchange thier shares for preferred stock on a 1000 for 1 basis, no details on how long they will need to hold them before they can be converted to common stock again. trying to reduce the tradeable float? with 6.6++ BILLION shares out they need to do something!!
Posted by Hitman on :
I own 1 million shares..... The swap may be a gr8 deal... just never know.... So my $100 is worth the risk to convert.... Could be worth lots of money in the future.... I will convert
Posted by netguy81 on :
i think i'm going to convert too ... its not like i have a fortune invested in this ... its only $100 ... so who knows after getting the preferred stock, the value someday might be more than $100 !!
Posted by tmanfromtexas on :
If enough folks convert it could be a win win for all. Lots of buys at 2. TMAN...
Posted by megahead34 on :
Say i have 1 million shares (common). If i convert, i will have 1000 preferred valued at $1.00?
They don't really explain how to convert. What process do we take?
Posted by MichaelAdamGreen on :
BUY MY SHARES AT .0002 WHAT GIVES!!!!!!!!!!!!!!
Posted by tmanfromtexas on :
Mega, Contact the TA...
Current shareholders must have their shares into OTC Corporate Transfer Service Company by May 4, 2007, unless extended by the Company, in order to qualify for the exchange of common shares to Series B Convertible Preferred Shares. In order to qualify for the exchange, shareholders must submit a minimum of 100,000 shares of common stock.
Posted by Gary59 on :
Only 4 MMs on bid now,,and all at .0001
Posted by Gary59 on :
Down to 3 MMs and a lot of shares just sold , dont look like they want to wait to transfer sh.. Not sure what I will do but only have 500000 sh and not sure how long would have to hold for transfer ,
Posted by madmoney on :
quote:Originally posted by megahead34: Say i have 1 million shares (common). If i convert, i will have 1000 preferred valued at $1.00?
They don't really explain how to convert. What process do we take?
most likely these will be restricted for one or two years and convertable at the stock price at that time in shares, so if the price "then" is .0001 they will convert into 10,000 shares of common "if" the price is less than .0001?????
Posted by madmoney on :
now ZIP by .0001!!! Posted by m69jump on :
yo.......mad
Posted by MichaelAdamGreen on :
Is anyone still in this? Any News? Updates? PR? WORD ON WHEN I'M GOING TO MAKE A RETURN ON MY $$$$$$$?
Posted by lukin4winners on :
LBTN just a matter of time for the approval of the technology.Lifeline Biotechnologies, Inc. to Release Initial Report on First Warning's(TM) New Algorithm May 1, 2007 8:31:00 AM Copyright Business Wire 2007 RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced that diagnostic success appears on the horizon for Lifeline's First Warning System(TM) which is designed to assist in the early detection of breast cancer. The company is expecting to soon release a promising initial report on its new algorithm developed by its study group.
Louis Keith, MD, PhD, Lifeline's Medical Director and Vice President, stated that on their recent visit to SE Asia, he and Jim Holmes, Lifeline's CEO, met with two eminent scientists of a prestigious technical university, engineers in the field of pattern recognition. These engineers, associated with Lifeline during the last three years, are assisting the Company in the development of new neural networks and have been working with the process to eliminate noise for the patient thermal data recorded by the First Warning System(TM). Thus far, the preliminary results have produced much better results in terms of reducing false positive and false negative interpretations.
Jim Holmes stated, "The Company's next step is to examine a larger group of women to verify what we have discovered."
Posted by Chris4205 on :
Alot of pre market volume 26,666,700
Posted by StockBoy10 on :
![[Big Grin]](biggrin.gif)
![[Roll Eyes]](rolleyes.gif)
![[Eek!]](eek.gif)